Skip to content
Screener

Current Debt at other companies

Danaher logo
DanaherDHR
$1.41B+181%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$500K0.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$5.46M+5,471%
Revvity logo
RevvityRVTY
$575.83M+237,847%
Agilent Technologies logo
Agilent TechnologiesA
$304M+108%

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059

FAQ

What is Maravai LifeSciences Holdings, Inc.'s current debt?
Maravai LifeSciences Holdings, Inc. (MRVI) reported current debt of $1.13M in Q2 2026.
How has Maravai LifeSciences Holdings, Inc.'s current debt changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s current debt decreased by 79.3% year-over-year, from $5.44M to $1.13M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s current debt?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s current debt has grown at a -1.9% compound annual growth rate (CAGR), from $6M to $5.44M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude